Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial design
Pharma
FDA docs shed light on contentious nod for Replimune's Trudiqev
Leaders at CBER's Office of Clinical Evaluation and the Oncology Center of Excellence recommended an accelerated approval for Trudiqev.
Fraiser Kansteiner
Sep 3, 2026 12:10pm
Teva debuts innovation platform to parry key industry challenges
Nov 19, 2025 8:38am
Fierce Biotech
Lilly oncology head weighs in on FDA cancer drug policies
Oct 21, 2025 11:53am
FDA official chastises Aurinia med in now-deleted LinkedIn post
Sep 30, 2025 10:15am
Trade group issues challenge to politicians ahead of UK election
Jun 11, 2024 2:30pm
